Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Irritable Bowel Syndrome

Free Subscription 01.06.2026 1 Aliment Pharmacol Ther 1 Biochem Biophys Res Commun 1 Biology (Basel) 1 Biomedicines 1 Biopsychosoc Sci Med 1 BMC Gastroenterol 1 Brain Behav Immun 1 Brain Spine 1 Cell Rep 1 Curr Res Microb Sci 1 EPMA J 1 Front Cell Infect Microbiol 1 Front Med (Lausanne) 1 Front Neurosci 1 Front Psychol 1 Front Public Health 1 Gastro Hep Adv 1 Gastroenterology 1 Healthcare (Basel) 1 Int J Pediatr 1 Integr Med Res 1 J Clin Med 1 J Comp Eff Res 1 J Epidemiol Glob Health 1 J Gastroenterol Hepatol 2 Neurogastroenterol Motil 2 Nutrients 1 Pharmaceuticals (Basel) 1 PLoS One 1 Sci Rep 1 Singapore Med J

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Aliment Pharmacol Ther

1. VELDMAN F, Innocenti F, Aziz I, Fikree A, et al
   Prevalence and Burden of Fatigue Across Disorders of Gut-Brain Interaction: Results From the Rome Foundation Global Epidemiology Study.
   Aliment Pharmacol Ther. 2026 May 28. doi: 10.1111/apt.70756.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

2. WANG X, Wei Y, Wang M, Zhang Y, et al
   Deciphering the multi-target mechanism of Magnolia officinalis in irritable bowel syndrome with diarrhea: A combined network pharmacology, machine learning, and in vivo validation study.
   Biochem Biophys Res Commun. 2026;825:153989.
   PubMed         Abstract available
   
   

   
   Biology (Basel)

3. ZHEN J, Zhou Z, Zhu R, Kuang M, et al
   Research Progress on the Role of Lactobacillus reuteri in Irritable Bowel Syndrome: A Review.
   Biology (Basel). 2026;15:808.
   PubMed         Abstract available
   
   

   
   Biomedicines

4. CANDREA AR, Gavrilas LI, Mocan A, Rusu A, et al
   Comparative Analysis of Gut Microbiota Patterns in Irritable Bowel Syndrome, Anxiety, and Autoimmune Disorders.
   Biomedicines. 2026;14:1005.
   PubMed         Abstract available
   
   

   
   Biopsychosoc Sci Med

5. ATANASOVA K, Mellein S, Knoedler LL, Niehaus VD, et al
   Gastrointestinal-specific Anxiety in IBD: Associations with Disease Activity, Psychological Symptoms, and Serotonergic Polymorphisms.
   Biopsychosoc Sci Med. 2026 May 26. doi: 10.1097/PSY.0000000000001493.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

6. PRASAD S, Nagda J, Ahuja A, Agrawal S, et al
   ACE inhibitor-induced isolated intestinal angioedema mimicking functional bowel disorder: a case report.
   BMC Gastroenterol. 2026 May 27. doi: 10.1186/s12876-026-04935.
   PubMed         Abstract available
   
   

   
   Brain Behav Immun

7. STEEN OD, Ohlsson H, van Ockenburg SL, Kendler KS, et al
   Shared genetic risk between functional somatic syndromes, internalizing disorders, and immune-mediated diseases: a twin-sibling study.
   Brain Behav Immun. 2026;137:106837.
   PubMed         Abstract available
   
   

   
   Brain Spine

8. IZIMA C, Khan FA, Ayloo B, Fuller JS, et al
   Irritable bowel syndrome and its impact on utilization and outcomes in elective thoracolumbar fusion.
   Brain Spine. 2026;6:106087.
   PubMed         Abstract available
   
   

   
   Cell Rep

9. XU J, Wei G, Wang J, Wang H, et al
   Milk extracellular vesicles attenuate pre-inflammatory bowel disease via Lctobacillus murinus-mediated TLR2 signaling modulation.
   Cell Rep. 2026;45:117438.
   PubMed         Abstract available
   
   

   
   Curr Res Microb Sci

10. SONG S, Han M, Moon K, Lee H, et al
    Bifidobacterium stercoris KC84 attenuates IBS-D-like symptoms via modulation of serotonin-related pathways and dendritic cell-mediated IFN-beta induction.
    Curr Res Microb Sci. 2026;10:100603.
    PubMed         Abstract available
    
    

    
    EPMA J

11. KUBATKA P, Kapinova A, Bojkova B, Joseph V, et al
    From sympathetic overdrive phenotype to malignant transformation: 3PM-guided protection against health-to-disease transition and disease progression improving individual outcomes in primary and secondary care.
    EPMA J. 2026;17:205-232.
    PubMed         Abstract available
    
    

    
    Front Cell Infect Microbiol

12. MORA GUZMAN Z, Bazan Salinas IL, Moreno-Cabral S, Perez-Campos E, et al
    Probiotics in irritable bowel syndrome: strain-specific effects, diet, and biomarker timing.
    Front Cell Infect Microbiol. 2026;16:1794927.
    PubMed        
    
    

    
    Front Med (Lausanne)

13. LI Q, Mo JH, Chen HQ, Chen MX, et al
    Translation, cross-cultural adaptation and validation of the Chinese version of irritable bowel syndrome severity scoring system.
    Front Med (Lausanne). 2026;13:1779402.
    PubMed         Abstract available
    
    

    
    Front Neurosci

14. ZHANG Y, Gao L, Zhang X, Sun W, et al
    Application of neuromodulation techniques in irritable bowel syndrome.
    Front Neurosci. 2026;20:1792685.
    PubMed         Abstract available
    
    

    
    Front Psychol

15. ALSAUD AS, Aldoweesh OH, Aljurayyed SM, Alharbi FB, et al
    Association between eating disorders and functional gastrointestinal disorders: a systematic review.
    Front Psychol. 2026;17:1785045.
    PubMed         Abstract available
    
    

    
    Front Public Health

16. QALAWA SAA, Elbqry MG, Elmansy FM, Almunif AT, et al
    Dietary habits and their association with irritable bowel syndrome among the public population in Saudi Arabia: a multicenter based study.
    Front Public Health. 2026;14:1804238.
    PubMed         Abstract available
    
    

    
    Gastro Hep Adv

17. DENG LX, Almario CV, Lai JC, Spiegel BMR, et al
    Characterizing Abdominal Pain and Irritable Bowel Syndrome Among Individuals With Cirrhosis: Results of a Nationwide Survey.
    Gastro Hep Adv. 2026;5:100976.
    PubMed        
    
    

    
    Gastroenterology

18. BURISCH J, Marsiglio M, Keszthelyi D
    Consensus on Irritable Bowel Syndrome-like Symptoms in Inflammatory Bowel Disease: A Step Toward Advancing Patient-Centered Care.
    Gastroenterology. 2026 May 25:S0016-5085(26)06931.
    PubMed        
    
    

    
    Healthcare (Basel)

19. BAE Y, Seo S, Jeon SR, Dong JJ, et al
    Long-Term Risk of Parkinson's Disease Following Irritable Bowel Syndrome: A Nationwide Population-Based Cohort Study.
    Healthcare (Basel). 2026;14:1329.
    PubMed         Abstract available
    
    

    
    Int J Pediatr

20. MAJOR J, Vargay A, Adam S
    School-Related Stressors, Pain Outcome Measures and Extremely Low Health-Related Quality of Life in a Representative Sample of Hungarian Adolescents With Functional Abdominal Pain Disorders.
    Int J Pediatr. 2026;2026:9964179.
    PubMed         Abstract available
    
    

    
    Integr Med Res

21. CHOI Y, Ha NY, Kim AR, Kwon O, et al
    Efficacy and safety of modified Gwakjeongtang (herbal medicine) for diarrhea-predominant irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial.
    Integr Med Res. 2026;15.
    PubMed         Abstract available
    
    

    
    J Clin Med

22. DEMIRCI FK, Koca TG, Elmas A, Akcam M, et al
    Sucrase-Isomaltase Deficiency in Children with Functional Gastrointestinal Disorders.
    J Clin Med. 2026;15:3639.
    PubMed         Abstract available
    
    

    
    J Comp Eff Res

23. MILLOVICH V, Shingara IO, Lopes GS, Tyagi M, et al
    Comparing characteristics and outcomes between hospitalized adults on a pea protein or dairy/soy protein formulas: initial findings.
    J Comp Eff Res. 2026 May 26:e260035. doi: 10.57264/cer-2026-0035.
    PubMed         Abstract available
    
    

    
    J Epidemiol Glob Health

24. ABDELAZIZ MN, Abdallah O, Bshar AM, Alqenawy M, et al
    Cardiometabolic Burden of Irritable Bowel Syndrome: A Case-Control Analysis of Metabolic Syndrome Clustering.
    J Epidemiol Glob Health. 2026;16:64.
    PubMed         Abstract available
    
    

    
    J Gastroenterol Hepatol

25. HE Y
    Re-Evaluating Probiotic Efficacy in Irritable Bowel Syndrome: A Call for Rigorous Statistics, Digital Therapeutics, and Microbiome-Driven Precision.
    J Gastroenterol Hepatol. 2026 May 29. doi: 10.1111/jgh.70459.
    PubMed        
    
    

    
    Neurogastroenterol Motil

26. HEATH MR, Abber SR, Luo Y
    Beyond the Gut: How to Integrate Psychological Screening Into the Standard of Care for Irritable Bowel Syndrome?
    Neurogastroenterol Motil. 2026;38:e70345.
    PubMed        
    
    
27. VASANT DH, Kinsinger SW
    Evidence That Remote Group Gut-Directed Hypnotherapy Is Feasible and Effective-Positive Implications for Integrated Irritable Bowel Syndrome Care.
    Neurogastroenterol Motil. 2026;38:e70364.
    PubMed        
    
    

    
    Nutrients

28. LAMBIASE C, Cancelli L, Tedeschi R, Grosso A, et al
    Effects of gamma-Aminobutyric Acid (GABA) Supplementation on Symptoms, Quality of Life, Intestinal Permeability, Systemic Inflammation and Gut Microbiota in Patients with IBS-D: A Randomized, Double Blind, Placebo-Controlled, Crossover Pilot Study.
    Nutrients. 2026;18:1569.
    PubMed         Abstract available
    
    
29. MOTOYAMA M, Yamada H, Yoshimura C, Matsunaga H, et al
    Clinical Utility of Anti-Gliadin IgG Antibody (AGA IgG) and Characterization of Patients with Suspected Non-Celiac Gluten Sensitivity: Prospective, Observational Study in Japan.
    Nutrients. 2026;18:1607.
    PubMed         Abstract available
    
    

    
    Pharmaceuticals (Basel)

30. PASTRAS P, Aggeletopoulou I, Psalti V, Triantos C, et al
    Gut Microbiota in Irritable Bowel Syndrome and Inflammatory Bowel Disease: Differences in Pathophysiology, Biomarkers, and Treatment Implications.
    Pharmaceuticals (Basel). 2026;19:783.
    PubMed         Abstract available
    
    

    
    PLoS One

31. WONNEMANN M, Lipowicz B, Duysburgh C, Rotsaert C, et al
    Repeated dosing of myrrh, chamomile extract, and coffee charcoal reveals potential health-beneficial effects in patients with irritable bowel syndrome in the M-SHIME simulator.
    PLoS One. 2026;21:e0348791.
    PubMed         Abstract available
    
    

    
    Sci Rep

32. CHEN X, Wang Y, Hou Y, Zhang L, et al
    Distinct psychophysiological biomarkers and risk stratification models for irritable bowel syndrome with constipation (IBS-C) and diarrhea (IBS-D).
    Sci Rep. 2026 May 25. doi: 10.1038/s41598-026-50456.
    PubMed         Abstract available
    
    

    
    Singapore Med J

33. ANG D
    Irritable bowel syndrome management: current insights.
    Singapore Med J. 2026;67:309-313.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Irritable Bowel Syndrome is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum